Improving Co-benefits and 'Triple Win' Impacts from Climate Action: The Role of Guidance Tools

This CDI Practice Paper by L.O. Naess, M. Hagemann, B. Harvey, F. Urban, S. Hendel-Blackford and N. Höhne addresses the role of tools in supporting interventions to achieve the ‘triple wins’ of adaptation, mitigation and development. Over recent years there has been a proliferation of guidance tools to support adaptation or mitigation, increasingly in a development context, but little work on the role tools play in helping to bridge the gap between these three areas in practice. Based on a review of tools in view of ‘climate compatible development’, the paper suggests key considerations for how tools could help achieve ‘triple wins’. They include (1) the importance of understanding how tools are a way of defining and shaping a goal, not merely helping to implement actions to achieve it; (2) the value of acknowledging different starting points, and that a lot of the integration is happening – and will continue to happen – on the side of users; and (3) because tools cannot provide all the answers to complex problems they need to be complemented by analysis of actors, goals and outcomes.UK Department for International Developmen

Natural feed additives as alternative to in-feed medication

The use of antibiotics in livestock production is very common and widespread. The reason for their use can be very diverse. Examples are the treatment of clinically sick animals, the improvement of growth performance, as well as the prevention of common bacterial infections. However, the extensive use of such antimicrobials raised concerns of increasing the incidence of resistant pathogenic bacteria, which has a negative impact not only on livestock production, but also on human health. In the last years, many different substances have been investigated as suitable alternatives to the use of antibiotics as growth promoting agents and as prophylactic substances

2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry

Objectives: Specifically we aim to demonstrate that the results of our earlier safety data hold true in this much larger multi-national and multi-ethnical population. Background: We sought to re-evaluate the frequency, manifestations, and severity of acute adverse reactions associated with administration of several gadolinium- based contrast agents during routine CMR on a European level. Methods: Multi-centre, multi-national, and multi-ethnical registry with consecutive enrolment of patients in 57 European centres. Results: During the current observation 37788 doses of Gadolinium based contrast agent were administered to 37788 patients. The mean dose was 24.7 ml (range 5–80 ml), which is equivalent to 0.123 mmol/kg (range 0.01 - 0.3 mmol/kg). Forty-five acute adverse reactions due to contrast administration occurred (0.12 %). Most reactions were classified as mild (43 of 45) according to the American College of Radiology definition. The most frequent complaints following contrast administration were rashes and hives (15 of 45), followed by nausea (10 of 45) and flushes (10 of 45). The event rate ranged from 0.05 % (linear non-ionic agent gadodiamide) to 0.42 % (linear ionic agent gadobenate dimeglumine). Interestingly, we also found different event rates between the three main indications for CMR ranging from 0.05 % (risk stratification in suspected CAD) to 0.22 % (viability in known CAD). Conclusions: The current data indicate that the results of the earlier safety data hold true in this much larger multi-national and multi-ethnical population. Thus, the “off-label” use of Gadolinium based contrast in cardiovascular MR should be regarded as safe concerning the frequency, manifestation and severity of acute events

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

We compared morphologic computed tomography (CT)-based to metabolic fluoro-deoxy-glucose (FDG) positron emission tomography (PET)/CT-based response evaluation in patients with metastatic colorectal cancer and correlated the findings with survival and KRAS status. From 2006 to 2009, patients were included in a phase II trial and treated with cetuximab and irinotecan every second week. They underwent FDG-PET/CT examination at baseline and after every fourth treatment cycle. Response evaluation was performed prospectively according to Response Evaluation Criteria in Solid Tumors (RECIST 1.0) and retrospectively according to Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST). Best overall responses were registered. Sixty-one patients were eligible for response evaluation. Partial response (PR) rate was 18%, stable disease (SD) rate 64%, and progressive disease (PD) rate 18%. Partial metabolic response (PMR) rate was 56%, stable metabolic disease rate 33%, and progressive metabolic disease (PMD) rate 11%. Response agreement was poor, κ-coefficient 0.19. Hazard ratio for overall survival for responders (PR/PMR) versus nonresponders (PD/PMD) was higher for CT- than for FDG-PET/CT evaluation. Within patients with KRAS mutations, none had PR but 44% had PMR. In conclusion, morphologic and metabolic response agreement was poor primarily because a large part of the patients shifted from SD with CT evaluation to PMR when evaluated with FDG-PET/CT. Furthermore, a larger fraction of the patients with KRAS mutations had a metabolic treatment response

Comparison of observed with model hadron charge ratio of secondary cosmic rays

The validity of previous comparisons between model results and observations of the neutral to charged ratio of hadrons in the atmosphere is re-examined. The authors then select the most appropriate published data plus data taken by the authors at Chacaltaya and compare them with model results.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/48864/2/jgv2i4pL61.pd

The universally growing mode in the solar atmosphere: coronal heating by drift waves

The heating of the plasma in the solar atmosphere is discussed within both frameworks of fluid and kinetic drift wave theory. We show that the basic ingredient necessary for the heating is the presence of density gradients in the direction perpendicular to the magnetic field vector. Such density gradients are a source of free energy for the excitation of drift waves. We use only well established basic theory, verified experimentally in laboratory plasmas. Two mechanisms of the energy exchange and heating are shown to take place simultaneously: one due to the Landau effect in the direction parallel to the magnetic field, and another one, stochastic heating, in the perpendicular direction. The stochastic heating i) is due to the electrostatic nature of the waves, ii) is more effective on ions than on electrons, iii) acts predominantly in the perpendicular direction, iv) heats heavy ions more efficiently than lighter ions, and v) may easily provide a drift wave heating rate that is orders of magnitude above the value that is presently believed to be sufficient for the coronal heating, i.e., $\simeq 6 \cdot 10^{-5}$J/(m$^3$s) for active regions and $\simeq 8 \cdot 10^{-6}$J/(m$^3$s) for coronal holes. This heating acts naturally through well known effects that are, however, beyond the current standard models and theories.Comment: To appear in MNRA

Repair of gaps opposite lesions by homologous recombination in mammalian cells

Damages in the DNA template inhibit the progression of replication, which may cause single-stranded gaps. Such situations can be tolerated by translesion DNA synthesis (TLS), or by homology-dependent repair (HDR), which is based on transfer or copying of the missing information from the replicated sister chromatid. Whereas it is well established that TLS plays an important role in DNA damage tolerance in mammalian cells, it is unknown whether HDR operates in this process. Using a newly developed plasmid-based assay that distinguishes between the three mechanisms of DNA damage tolerance, we found that mammalian cells can efficiently utilize HDR to repair DNA gaps opposite an abasic site or benzo[a]pyrene adduct. The majority of these events occurred by a physical strand transfer (homologous recombination repair; HRR), rather than a template switch mechanism. Furthermore, cells deficient in either the human RAD51 recombination protein or NBS1, but not Rad18, exhibited decreased gap repair through HDR, indicating a role for these proteins in DNA damage tolerance. To our knowledge, this is the first direct evidence of gap-lesion repair via HDR in mammalian cells, providing further molecular insight into the potential activity of HDR in overcoming replication obstacles and maintaining genome stability